Norkunas Matthew
SEC insider (Form 3/4/5 filer). CIK 0001816836. Director at Obsidian Therapeutics, Inc. (OBX) and 1 other issuer. 5 reported Form 4/5 transactions since Sep 2024; latest on Aug 3, 2026. Located in CAMBRIDGE, MA.
Companies Norkunas Matthew has filed insider reports for
- Obsidian Therapeutics, Inc. (OBX): Director
- Generation Bio Co. (GBIO): Officer, CHIEF FINANCIAL OFFICER
Norkunas Matthew
CIK: 0001816836
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (40.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Aug 3, 2026OBX
Obsidian Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
37.7K shares- - Oct 15, 2024GBIO
Generation Bio Co.
ExerciseDirect1.7K shares- - Oct 15, 2024GBIO
Generation Bio Co.
Tax PaymentDirect492 shares at avg. $2.42$1K - Oct 15, 2024GBIO
Generation Bio Co.
ExerciseDirect1.7K shares- - Oct 15, 2024GBIO
Generation Bio Co.
Tax PaymentDirect492 shares at avg. $2.42$1K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 3, 2026 |  OBX Obsidian Therapeutics, Inc. | Award Stock Option (Right to Buy) | 37,653 | - | - | Direct |
| Oct 15, 2024 |  GBIO Generation Bio Co. | Exercise | 1,674 | - | $0 | Direct |
| Oct 15, 2024 | GBIO Generation Bio Co. | Tax Payment | 492 | $2.42 | $1,191 | Direct |
| Oct 15, 2024 | GBIO Generation Bio Co. | Exercise | 1,673 | - | $0 | Direct |
| Oct 15, 2024 | GBIO Generation Bio Co. | Tax Payment | 492 | $2.42 | $1,191 | Direct |
1-5 of 5 transactions